Related Experiment Videos
B-type natriuretic peptide in cardiovascular disease
James A de Lemos1, Darren K McGuire, Mark H Drazner
1Donald W Reynolds Cardiovascular Clinical Research Center and Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9047, USA. james.delemos@utsouthwestern.edu <james.delemos@utsouthwestern.edu>
Lancet (London, England)
|August 2, 2003
Summary
Natriuretic peptide hormones aid in diagnosing and treating cardiovascular diseases. Measuring B-type natriuretic peptide (BNP) and N-terminal BNP helps assess heart failure and prognosis.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Biochemistry
Background:
- Natriuretic peptides are vasoactive hormones with beneficial physiological effects.
- They are crucial in cardiovascular disease management.
- Translational research is advancing their clinical application.
Purpose of the Study:
- To review the physiology of the natriuretic peptide system.
- To discuss the diagnostic and prognostic utility of B-type natriuretic peptide (BNP) and N-terminal BNP in heart failure.
- To explore therapeutic applications of BNP and related agents.
Main Methods:
- Review of physiological roles of natriuretic peptides.
- Analysis of clinical studies measuring BNP and N-terminal BNP.
- Examination of therapeutic strategies involving BNP (nesiritide) and vasopeptidase inhibitors.
Main Results:
- BNP and N-terminal BNP measurements are effective for diagnosing heart failure and left ventricular dysfunction.
- These biomarkers also predict prognosis in patients with cardiac conditions.
- Nesiritide and vasopeptidase inhibitors show potential in heart failure treatment.
Conclusions:
- The natriuretic peptide system is vital for cardiovascular health and disease management.
- Biomarkers like BNP and N-terminal BNP offer significant diagnostic and prognostic value.
- Therapeutic interventions targeting this system hold promise for improving patient outcomes.